P.A.W. Capital’s Aptose Biosciences, Inc. APTO Stock Holding History

P.A.W. Capital’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,256	Closed	-$336K	–	57
2022 Q3	$336K	Hold	1,256	–	–	0.5%	50
2022 Q2	$419K	Hold	1,256	–	–	0.61%	52
2022 Q1	$768K	Hold	1,256	–	–	0.8%	53
2021 Q4	$763K	Sell	1,256 -411	-25%	-$386K	0.7%	56
2021 Q3	$1.64M	Buy	1,667 +111	+7%	+$139K	1.45%	22
2021 Q2	$2.32M	Buy	1,556 +23	+2%	+$50.1K	1.95%	17
2021 Q1	$4.12M	Sell	1,533 -134	-8%	-$266K	3.63%	8
2020 Q4	$3.29M	Buy	1,667 +111	+7%	+$261K	2.9%	10
2020 Q3	$4.2M	Buy	1,556 +223	+17%	+$556K	4.57%	4
2020 Q2	$3.79M	Hold	1,333	–	–	4.28%	5
2020 Q1	$3.56M	Sell	1,333 -178	-12%	-$531K	4.8%	1
2019 Q4	$3.86M	Buy	1,511 +400	+36%	+$521K	4.11%	6
2019 Q3	$1.04M	Buy	+1,111	New	+$1.26M	1.3%	24

Other funds holding APTO

DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return

Annandale Capital Dallas, Texas $733M AUM 11.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

P.A.W. Capital's APTO Position: Q4 2022 in Review

P.A.W. Capital sold out of Aptose Biosciences, Inc. (APTO) in Q4 2022, closing a stake of 1,256 shares — an estimated $336K sold.

P.A.W. Capital first reported a position in APTO in Q3 2019 and held it in 13 quarters. The position peaked at $4.2M in Q3 2020. 47 funds tracked by Wall St. Rank hold APTO as of Q4 2022.

P.A.W. Capital reported no remaining Aptose Biosciences, Inc. position as of Q4 2022 after selling out during the quarter.
P.A.W. Capital sold 1,256 Aptose Biosciences, Inc. shares in Q4 2022, an estimated $336K.
P.A.W. Capital first reported a position in Aptose Biosciences, Inc. in Q3 2019 and held it in 13 quarters.
P.A.W. Capital's Aptose Biosciences, Inc. position peaked at $4.2M in Q3 2020.
47 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2022.

Based on P.A.W. Capital's 13F filing for Q4 2022, filed 14 Feb 2023.